期刊文献+

C3胞外酶抑制缓激肽诱导的血肿瘤屏障通透性的增加 被引量:3

C_3 Exoenzyme Inhibits Bradykinin-induced Selective Increase of the Permeability of Blood-tumor Barrier
下载PDF
导出
摘要 目的研究Ras基因家族成员A(RhoA)的特异性抑制剂C3胞外酶(exoenzyme)对缓激肽诱导的血肿瘤屏障通透性的作用。方法应用C3 exoenzyme预处理大鼠原代脑微血管内皮细胞后,测量跨内皮阻抗值(TEER)、辣根过氧化物酶(HRP)流量,分析血肿瘤屏障的通透性的改变;应用Western blot检测紧密连接相关蛋白(ZO-1)的表达;应用免疫荧光法观察原代大鼠脑微血管内皮细胞紧密连接相关蛋白ZO-1和丝状肌动蛋白(F-actin)结构和分布的改变。结果 C3 exoenzyme显著抑制缓激肽诱导TEER值的降低、HRP流量的升高及ZO-1的表达,抑制ZO-1由内皮细胞的边缘向细胞质转移,抑制丝状肌动蛋白由细胞膜边缘向细胞中央区分布,分布于细胞边缘的F-actin明显增加,应力纤维形成明显减少。结论 RhoA能够介导缓激肽开放血肿瘤屏障。 Objective To investigate the effect of C3 exoenzymea,specific Ras homolog gene family member A(RhoA)inhibitoro,n bradykinin(BK)-induced increase in blood-tumor barrier(BTB)permeability.Methods Rat brain microvascular endothelail cells(RB-MECs)were pretreated with C3 exoenzyme and then treated with BK for 15 minutes.Horseradish peroxidase(HRP)flux and TEER assays were employed to reveal BTB permeability.The protein expression level of ZO-1 was observed by Western blot.The stress fiber formation and distribution of filamentous actin(F-actin)and ZO-1 were assessed by immunofluorescence microscopy.Results C3 exoenzyme could par-tially inhibit endothelial leakage and restored normal TEER values in RBMECs.The expression level of ZO-1 protein decreased significantly and it was prevented by C3 exoenzyme.C3 exoenzyme inhibited BK-induced relocation of ZO-1 from cellular borders into the cytoplasm as well as stress fiber formation in RBMECs.Conclusion RhoA plays a key role in BK-induced openning of blood-tumor barrier.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第2期97-100,共4页 Journal of China Medical University
基金 国家自然科学基金资助项目(30872656,30670723,30973079) 高等学校博士学科点专项科研基金资助项目(20092104110015) 沈阳市科学技术计划项目(1072033-1-00,1081266-9-00)
关键词 RHOA 缓激肽 血肿瘤屏障 紧密连接 ZO-1 肌动蛋白重排 RhoA bradykinin blood-tumor barrier tight junction ZO-1 actin rearrangement
  • 相关文献

参考文献13

  • 1Siegal T,Zylber-Katz E. Strategies for increasing drug delivery to the brain: focus on brain lymphoma [ J ]. Clin Pharmacokinet, 2002,41(3):171-186.
  • 2Erdlenbruch B,Schinkhof C,Kugler W,et al. lntracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain [J]. Br J Pharmacol,2003,139 (4): 685-694.
  • 3Samoto K, Perng GC, Ehtesham M, et al. A herpes simplex virus type 1 mutant deleted for gamma 34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation [J]. Cancer Gene Ther, 2001,8(4) : 269-277.
  • 4刘丽波,薛一雪,王萍.缓激肽对脑胶质瘤大鼠occludin和ZO-1 mRNA的调节和机制[J].中国医科大学学报,2010,39(7):497-500. 被引量:5
  • 5Baumer Y,Spindler V,Werthmann RC,et al. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown [ J ]. J Cell Physiol, 2009,220(3 ) : 716-726.
  • 6Liu LB,Xue YX,Liu YH,et al. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO- 1, occludin, and claudin-5 and rearranging aetin cytoskeleton [ J ]. J Neurosci Res, 2008,86(5 ) : 1153-1168.
  • 7Meiri D,Greeve MA,Brunet A,et al. Modulation of Rho guanine exchange factor Lfc activity by protein kinase A-mediated phosphorylation [J]. Mol Cell Biol,2009,29(21 ) :5963-5973.
  • 8Li B, Zhao WD,Tan ZM, et al. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells [ J]. FEBS Lett, 2006,580(17) : 4252-4260.
  • 9Easton AS, Abbott NJ. Bradykinin increases permeability by calcium and 5-1ipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier [J]. Brain Res, 2002,953( 1-2 ) : 157-169.
  • 10Nakagawa S, Deli MA, Kawaguchi H, et al. A new blood-brain barrier model using primary rat brain endothelial cells,pericytes and astrocytes [ J]. Neurochem Int, 2009,54 (3-4) : 253-263.

二级参考文献15

  • 1王振华,薛一雪,刘丽波,王萍.缓激肽诱导胶质瘤细胞内cAMP反应元件结合蛋白磷酸化的实验研究[J].中国药理学通报,2006,22(12):1444-1447. 被引量:4
  • 2Black KL, Ningaraj NS. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor [J]. Cancer Control, 2004,11 (3):165-173.
  • 3Inamura T, Black KL. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors [J]. J Cereb Blood Flow Metab, 1994, 14 (5) : 862-870.
  • 4Hashizume K, Black KL. Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4 [J]. J Neuropathol Exp Neurol, 2002,61 ( 8 ) : 725-735.
  • 5Sanovich E, Bartus RT, Friden PM, et al. Pathway across blood-brain barrier opened by the bradykinin agonist,RMP-7 [J]. Brain Res, 1995,705 ( 1-2 ) : ! 25-135.
  • 6Liu LB,Xne YX,Liu YH,et al. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO- 1,occludin,and claudin-5 and rearranging actin cytoskeleton [J]. J Neurosci Res, 2008,86 ( 5 ) : 1153- 1168.
  • 7Cruzalegui FH, Bading H. Calcium-regulated protein kinase cascades and their transcription factor targets [J ]. Cell Mol Life Sci, 2000,57 (3) :402-410.
  • 8Bernacki J,Dobrowolska A,Nierwinska K,et al. Physiology and pharmacological role of the blood-brain barrier [J]. Pharmacol Rep, 2008,60 ( 5 ) : 600-622.
  • 9Ballabh P,Braun A,Nedergaard M. The blood-brain barrier:an overview. Structure, regulation, and clinical implications [J ]. Neurobiol Dis, 2004 (1),16:1-13.
  • 10Fanning AS,Anderson JM. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions [ J ]. Ann N Y Acad Sci,2009, 1165 113-120.

共引文献4

同被引文献10

  • 1Black KI,Ningaraj NS. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor[J].Cancer Control:Journal of the Moffitt Cancer Center,2004,(03):165-173.
  • 2Nakagawa S,Deli MA,Kawaguchi H. A new blood-brain barrier model using primary rat brain endothelial cells,pericytes and astrocytes[J].Neurochemistry International,2009,(3-4):253-263.
  • 3Wojciak-Stothard B,Tsang LY,Paleolog E. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxiainduced neonatal pulmonary hypertension[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2006,(06):L1173-L1182.
  • 4Walsh SV,Hopkins AM,Chen J. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia[J].Gastroenterology,2001,(03):566-579.
  • 5Li B,Zhao WD,Tan ZM. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells[J].FEBS Letters,2006,(17):4252-4260.doi:10.1016/j.febslet.2006.06.056.
  • 6Calaminus SD,Auger JM,McCarty OJ. Myosinlla contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability[J].Journal of Thrombosis and Haemostasis,2007,(10):2136-2145.
  • 7Honjo M. The possibility of selective Rho-associated kinase (ROCK)inhibitors as a medical treatment for glaucoma[J].Nippon Ganka Gakkai Zasshi Acta Societatis Ophthalmological Japonicae,2009,(11):1071-1081.
  • 8Hopkins AM,Walsh SV,Verkade P. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function[J].Journal of Cell Science,2003,(Pt 4):725-742.
  • 9Van Itallie CM,Fanning AS,Bridges A. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton[J].Molecular Biology of the Cell,2009,(17):3930-3940.
  • 10Kouri FM,Hurley LA,Daniel WL,Day ES,Hua Y,Hao L,Peng CY,Merkel TJ,Queisser MA,Ritner C,Zhang H,James CD,Sznajder JI,Chin L,Giljohann DA,Kessler JA,Peter ME,Mirkin CA,Stegh AH.miR-182参与调节胶质母细胞瘤的凋亡、生长和分化(英文)[J].中华神经外科疾病研究杂志,2015,14(2):163-163. 被引量:13

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部